Rockwell Medical (RMTI) Closes $20M Debt Financing
Tweet
Share
E-mailGet Alerts RMTI Hot Sheet
Join SI Premium – FREE
Rockwell Medical (NASDAQ: RMTI) closed a $20 million debt financing with Hercules Technology Growth Capital, Inc.
"This $20 million straight-debt financing coupled with our recent $40 million equity financing provides us with sufficient cash to get SFP to commercial launch," stated Rob Chioini, Founder, Chairman and CEO of Rockwell Medical. "We are on schedule to release Phase 3 efficacy data for CRUISE-1 and look forward to those study results."
"This $20 million straight-debt financing coupled with our recent $40 million equity financing provides us with sufficient cash to get SFP to commercial launch," stated Rob Chioini, Founder, Chairman and CEO of Rockwell Medical. "We are on schedule to release Phase 3 efficacy data for CRUISE-1 and look forward to those study results."
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Denarius Metals acquires 15% stake in Copper Giant, Trafigura invests
- UDynamics files for Nasdaq IPO of 5.6 million shares at $5-$7 per share
- Boeing names Ryan Shedd as new SVP and controller
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
